Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$65,299,041
+$10,966,062 QoQ
Shares Held
693,785
+26.1% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 97.44791253774584.ToString("F0")%
Shared 0.ToString("F0")%
None 2.5520874622541565.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. INCY ranks #23 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in INCY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,299,041 | 693,785 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $54,332,979 | 550,096 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $44,485,218 | 524,528 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $29,096,607 | 427,263 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $37,122,716 | 613,092 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $23,813,743 | 344,777 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $13,333,556 | 201,718 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $15,270,540 | 251,906 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,735,289 | 258,650 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,375,400 | 53,757 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,420,908 | 41,906 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,200,598 | 35,351 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,301,147 | 211,722 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $16,668,647 | 207,528 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,369,451 | 20,550 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,422,840 | 18,729 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,815,834 | 35,455 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,648,564 | 36,084 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,447,603 | 35,586 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $521,436 | 6,198 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $398,465 | 4,903 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $441,596 | 5,077 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $432,636 | 4,821 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||